These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19182252)

  • 1. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.
    Damato B; Dopierala J; Klaasen A; van Dijk M; Sibbring J; Coupland SE
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3048-55. PubMed ID: 19182252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
    Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.
    Dopierala J; Damato BE; Lake SL; Taktak AF; Coupland SE
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4898-905. PubMed ID: 20484589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
    Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
    Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy between fluorescence in situ hybridization and multiplex ligation-dependent probe amplification in orbital recurrence of uveal melanoma 26 years after enucleation.
    Russo A; Rene C; Coupland SE; Sagili S; Damato B
    Ophthalmic Plast Reconstr Surg; 2012; 28(6):e140-2. PubMed ID: 22460679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma.
    Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
    Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
    Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplex ligation-dependent probe amplification analysis of uveal melanoma with extraocular extension demonstrates heterogeneity of gross chromosomal abnormalities.
    Lake SL; Damato BE; Dopierala J; Baudo MM; Taktak AF; Coupland SE
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5559-64. PubMed ID: 21659309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.
    van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma.
    Caines R; Eleuteri A; Kalirai H; Fisher AC; Heimann H; Damato BE; Coupland SE; Taktak AF
    Mol Vis; 2015; 21():1-11. PubMed ID: 25684974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients.
    Kilic E; Naus NC; van Gils W; Klaver CC; van Til ME; Verbiest MM; Stijnen T; Mooy CM; Paridaens D; Beverloo HB; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2253-7. PubMed ID: 15980208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma.
    Singh AD; Tubbs R; Biscotti C; Schoenfield L; Trizzoi P
    Arch Pathol Lab Med; 2009 Aug; 133(8):1223-7. PubMed ID: 19653714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
    Parrella P; Caballero OL; Sidransky D; Merbs SL
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
    Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.